With so many shares to choose from on the ASX, it can be difficult to decide which ones to buy. The good news is that brokers across the country are doing a lot of the hard work for you.
Three top ASX shares that leading brokers have named as buys this week are listed below. Here's why they are bullish on them:
Accent Group Ltd (ASX: AX1)
According to a note out of Morgans, its analysts have retained their add rating and $2.30 price target on this footwear retailer's shares. Although Accent's half year results were short of expectations, the broker remains positive. Particularly given that comparable sales will get less demanding as the half goes on. Morgans expects this to lead to positive like for like sales for the second half. The Accent share price is trading at $1.96 today.
Pro Medicus Limited (ASX: PME)
A note out of Macquarie reveals that its analysts have retained their outperform rating and $120.00 price target on this health imaging technology company's shares. The broker believes that recent share price weakness has created a buying opportunity for investors. Especially now they are trading on multiples that are largely in line with five-year averages. The Pro Medicus share price is fetching $98.39 on Monday.
Xero Ltd (ASX: XRO)
Analysts at Goldman Sachs have reiterated their buy rating and $141.00 price target on this cloud accounting platform provider's shares. The broker is feeling positive on Xero's outlook ahead of its investor day event this week. It highlights that it is forecasting revenue to grow to NZ$3 billion by FY 2028. This represents a 16% CAGR (14% subs growth and +2% ARPU). The Xero share price is trading at $122.72 this afternoon.
